Featured Trials

National Lung Screening Trial

Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer (NCIC-MA27)

Phase III Randomized Study of Two Different Schedules of Adjuvant Cyclophosphamide and Doxorubicin Versus Paclitaxel in Women With Operable Breast Cancer and 0-3 Positive Axillary Lymph Nodes (CALGB-40101)

Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer (E5103)

TAILORx Breast Cancer Trial

Bevacizumab, Sorafenib, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer (ECOG-E2804)
Different combinations of bevacizumab, temsirolimus, and sorafenib compared with bevacizumab alone to treat patients with metastatic kidney cancer

Zoledronic Acid and Prostate Cancer (CALGB-90202)
Early vs. standard zoledronic acid and prostate cancer metastases

Flavopiridol and B-cell leukemia (CLLRC-OSU-049)
Flavopiridol for patients with previously treated B-cell leukemia

Sunitinib vs Sorafenib in Kidney Cancer (ECOG-E2805)
Adjuvant sunitinib vs sorafenib vs placebo in pts with resected renal cell carcinoma

Adding Bevacizumab or Cetuximab in Colorectal Cancer (CALGB-C80405)
Chemo plus bevacizumab or cetuximab or both for untreated metastatic colorectal cancer

Adding Bevacizumab in Advanced Ovarian Cancer (GOG-0218)
Chemotherapy and bevacizumab for women with advanced ovarian cancer

National Computed Tomography Colonography Trial (ACRIN 6664)